Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril Treatment of Claudication
NCT02842424Phase 4Active, not recruiting
- Sponsor
- University of Nebraska
- Start
- Feb 2016
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ramipril in Peripheral Arterial Disease (PAD), sponsored by University of Nebraska. Primary endpoint: Absolute Claudication Distance at 6 months. Started Feb 2016; status: active, not recruiting.
02
Drugs
ramipril
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02842424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02842424.